Laura L. Johnson - Jul 1, 2022 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
Director
Signature
/s/ Anthony Scott Praill, attorney-in-fact for Laura L. Johnson
Stock symbol
KTRA
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
7/5/2022, 04:05 PM
Previous filing
Jan 14, 2022
Next filing
Aug 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +100K $0.00 100K Jul 1, 2022 Common Stock 100K $0.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on August 1, 2022.